cfa – HedgeChatter

Technical Coverage on Biotech Stocks — Cytori Therapeutics, Oncolytics Biotech, BioMarin Pharma, Aeterna Zentaris …

LONDON, March 19, 2015 /PRNewswire/ —Editor Note: For more information about this release, please scroll to bottom.Investor-Edge has initiated coverage on the following equities: Cytori Therapeutics Inc. (NASDAQ: CYTX), Oncolytics Biotech Inc. (NASDAQ: ONCY), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), Aeterna Zentaris Inc. (NASDAQ: AEZS), and Immunomedics Inc. (NASDAQ: IMMU). Free research report on Cytori Therapeutics can be accessed at http://get.Investor-Edge.com/pdf/?c=Cytori%20Therapeutics&d=19-Mar-2015&s=CYTX. […]

March 19, 2015 cfa, CYTX, immunomedics, investor, investor-edge, oncolytics, pharmaceutical, therapeutics Comments Off read more

Biotech Stocks Technical Study — Orexigen Therapeutics, Celgene, PDL BioPharma, Amarin, and Synergy Pharma

LONDON, March 18, 2015 /PRNewswire/ —Editor Note: For more information about this release, please scroll to bottom.Investor-Edge has initiated coverage on the following equities: Orexigen Therapeutics Inc. (NASDAQ: OREX), Celgene Corporation (NASDAQ: CELG), PDL BioPharma Inc. (NASDAQ: PDLI), Amarin Corporation PLC (NASDAQ: AMRN), and Synergy Pharmaceuticals Inc. (NASDAQ: SGYP). Free research report on Orexigen Therapeutics can be accessed at http://get.Investor-Edge.com/pdf/?c=Orexigen%20Therapeutics&d=18-Mar-2015&s=OREX. […]

March 18, 2015 amarin, celgene, cfa, investor, investor-edge, nasdaq, pdl, pharmaceuticals, plc, rsi, stock, therapeutics Comments Off read more

Biotech Stocks Technical Report — Achillion Pharma, Arrowhead Research, Sunesis Pharma, Array BioPharma, and Seattle …

LONDON, December 22, 2014 /PRNewswire/ –Investor-Edge has initiated coverage on the following equities: Achillion Pharmaceuticals Inc. (NASDAQ: ACHN), Arrowhead Research Corporation (NASDAQ: ARWR), Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS), Array BioPharma Inc. (NASDAQ: ARRY), and Seattle Genetics Inc. (NASDAQ: SGEN). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Friday, December 19, 2014, ended on […]

December 22, 2014 arrowhead-research, cfa, edge-com, friday, genetics, investor-edge-com, nasdaq, pharmaceuticals, seattle, stock, sunesis Comments Off read more

Biotech Stocks in Motion – Amgen, Merrimack Pharma, NPS Pharma, BioMarin Pharma, and Regeneron Pharma

LONDON, November 24, 2014 /PRNewswire/ –Investor-Edge has initiated coverage on the following equities: Amgen Inc. (NASDAQ: AMGN), Merrimack Pharmaceuticals Inc. (NASDAQ: MACK), NPS Pharmaceuticals Inc. (NASDAQ: NPSP), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Friday, November 21, 2014, the NASDAQ Composite ended at 4,712.97, […]

November 24, 2014 additionally, AMGN, cfa, company, investor-edge, merrimack, nasdaq, NPSP, pharmaceuticals, regeneron, rsi, stock Comments Off read more

Nate Silver: “Buying Big Data to Solve Problems Is Oversold” | CFA …

Jason Voss, CFAAt the 67th CFA Institute Annual Conference in Seattle, Nate Silver, founder of FiveThirtyEight, delivered an important message to financial professionals about the appropriate uses and definite limitations of big data that was well worth its weight in gold.You would have to have been asleep for the last half-decade to not know that the business world, and consequently its […]

May 16, 2014 ByJason Voss CFA business, cfa, election, institute, japanese, national, opinion, real, relationships, seattle, states, united Comments Off read more

Social Finance: Have We Reached An Inflection Point? | CFA …

Len CostaIn his book The Intelligent Investor, Benjamin Graham expresses a distinct wariness, if not outright disdain, for the wisdom of crowds. “You are neither right nor wrong because the crowd disagrees with you,” he penned. “You are right because your data and reasoning are right.” These days, the increasingly robust intersection between social media and professional finance seems to […]

April 22, 2014 ByLen Costa academic, cfa, event, financial, industrial, private, social, stock, united Comments Off read more

Is The Stock Market's Smoothest Ride Priced Like A Cadillac …

By David L. Allison, CFA, CIPMHere’s a sure-fire way to get gouged: Walk onto a car lot, ask a salesperson to point out the vehicle with the smoothest ride, then purchase that vehicle regardless of price.It sounds reckless, but this is not far from the logic individual investors are using when shopping for the smoothest ride in the stock market.You […]

February 7, 2014 ByCFA Institute Contributors capital, cfa, highest, investing, investment, research, smoothest, stock, study, valuation, volatility Comments Off read more